Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thienopyridones as AMPK activators for the treatment of diabetes and obesity

Thienopyridones as AMPK activators for the treatment of diabetes and obesity

US Patent 7119205 · Granted Oct 10, 2006

Estimated economic value: $76,053,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Macromolecular prodrug-based thermosensitive injectable gel as a novel drug deli2025
Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors2025
Preparation method for silk fibroin nerve graft fused with NT32025
ASK1 inhibiting agents2025
Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-22025
SLAM polynucleotides and polypeptides and uses thereof2025
O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors2025
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methy2025
Nucleic acid nanoswitch construction methods2025
Optical connector and optical connector module and operation method using the sa2025
O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors2024
Hydroquinazoline derivatives for the treatment of a disease or disorder2024